Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ALI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ALI is a concept in neurodegeneration research. Key relationships include: implicated in, regulates, causes. Associated with SEPSIS. Connected to 146 entities in the SciDEX knowledge graph.
No AI portrait yet
Knowledge base pages for this entity
graph TD
ALI["ALI"]
S100A9["S100A9"] -->|"activates"| ALI
SEPSIS["SEPSIS"] -->|"causes"| ALI
CRH["CRH"] -->|"regulates"| ALI
MAP1B["MAP1B"] -->|"implicated in"| ALI
MAP2["MAP2"] -->|"implicated in"| ALI
MAP6["MAP6"] -->|"implicated in"| ALI
LIS1["LIS1"] -->|"implicated in"| ALI
DCX["DCX"] -->|"implicated in"| ALI
CD2AP["CD2AP"] -->|"implicated in"| ALI
HCN1["HCN1"] -->|"implicated in"| ALI| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| S100A9 | activates | protein | 0.72 |
| SEPSIS | causes | disease | 0.72 |
| CRH | regulates | protein | 0.64 |
| MMP9 | associated_with | protein | 0.60 |
| SMARCA4 | implicated_in | gene | 0.50 |
| CD40 | implicated_in | gene | 0.50 |
| VEGFA | implicated_in | gene | 0.50 |
| C1Q | implicated_in | gene | 0.50 |
| MCL1 | implicated_in | gene | 0.50 |
| SF3B1 | implicated_in | gene | 0.50 |
| NTN1 | implicated_in | gene | 0.50 |
| DNA | implicated_in | gene | 0.50 |
| PTN | implicated_in | gene | 0.50 |
| AQP4 | implicated_in | gene | 0.50 |
| C1QA | implicated_in | gene | 0.50 |
| MET | implicated_in | gene | 0.50 |
| GBM | implicated_in | gene | 0.50 |
| C1QC | implicated_in | gene | 0.50 |
| IRF3 | implicated_in | gene | 0.50 |
| SPI1 | implicated_in | gene | 0.50 |
| LDL | implicated_in | gene | 0.50 |
| UNC5B | implicated_in | gene | 0.50 |
| NBR1 | implicated_in | gene | 0.50 |
| GPNMB | implicated_in | gene | 0.50 |
| NPTX2 | implicated_in | gene | 0.50 |
| VGF | implicated_in | gene | 0.50 |
| HSPA1A | implicated_in | gene | 0.50 |
| NTN3 | implicated_in | gene | 0.50 |
| TARDBP | implicated_in | gene | 0.50 |
| SNRNP70 | implicated_in | gene | 0.50 |
| AGER | implicated_in | gene | 0.50 |
| TCR | implicated_in | gene | 0.50 |
| HSPA1B | implicated_in | gene | 0.50 |
| ERK1 | implicated_in | gene | 0.50 |
| ROS | implicated_in | gene | 0.50 |
| JNK | implicated_in | gene | 0.50 |
| PARP1 | implicated_in | gene | 0.50 |
| STING | implicated_in | gene | 0.50 |
| EEF1A1 | implicated_in | gene | 0.50 |
| IFN | implicated_in | gene | 0.50 |
| PRMT1 | implicated_in | gene | 0.50 |
| EGR1 | implicated_in | gene | 0.50 |
| G3BP1 | implicated_in | gene | 0.50 |
| ALS | implicated_in | gene | 0.50 |
| LC3 | implicated_in | gene | 0.50 |
| TOLLIP | implicated_in | gene | 0.50 |
| IDH1 | implicated_in | gene | 0.50 |
| FUS | implicated_in | gene | 0.50 |
| SQSTM1 | implicated_in | gene | 0.50 |
| IDH2 | implicated_in | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's di [PMID:39913287] | Ma Q, Tian JL, Lou Y, Guo R, Ma XR, Wu J | Cell Rep | 2025 | 1 |
| Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, P [PMID:40641018] | Raghuvanshi S, Mazumder A, Das S | CNS & neurological disorders d | 2026 | 0 |
| Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555] | Mishra AK, Jain S | ACS Chem Neurosci | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232] | Xie Z, Tu W, Ye XF, Hua L, Zhang X et al | Sci Rep | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural Regen Res | 2026 | 0 |
| Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359] | Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki | Journal of personalized medici | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | Burdman Gabriel; Akkaoui Juliet; Colon N | Neurology international | 2026 | 0 |
| Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318] | Seijo MA, Yohannes PA, Rogers AL, Gonzal | Res Sq | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural regeneration research | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | ["Burdman G", "Akkaoui J", "Colon N", "P | Neurology international | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| The APOE-Microglia Axis in Alzheimer's Disease: Functional Divergence and Therap [PMID:40722268] | Unknown | Brain sciences | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Axonal injury is a targetable driver of glioblastoma progression. [PMID:40836081] | Clements M, Tang W, Florjanic Baronik Z, | Nature | 2025 | 0 |
| Soluble CSF1R promotes microglial activation and amyloid clearance in alzheimer' [PMID:41152873] | Zhang L, Chen K, Zeng R | J Neuroinflammation | 2025 | 0 |
| Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and reg [PMID:39019902] | Nam J, Richie CT, Harvey BK | Sci Rep | 2024 | 0 |
| α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B sig [PMID:37410546] | Unknown | JCI Insight | 2023 | 0 |
| Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfuncti [PMID:36683512] | Basha SC, Ramaiah MJ, Kosagisharaf JR | J Alzheimers Dis | 2023 | 0 |
| CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567] | Guerreiro S, Privat AL, Bressac L, Toulo | Cells | 2020 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ALI in their description or question text
Score: 0.808 · neurodegeneration · 2026-04-15
## Mechanistic Overview Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation sta
Score: 0.798 · neurodegeneration · 2026-04-17
## Mechanistic Overview Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector starts from the claim that
Score: 0.776 · neurodegeneration · 2026-04-16
## Mechanistic Overview CX3CR1-TREM2 Integration for Synapse Pruning Normalization starts from the claim that modulating
Score: 0.769 · unknown disease · 2026-04-12
## Mechanistic Overview Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling starts from the cla
Score: 0.763 · neuroscience · 2026-04-22
**Molecular Mechanism and Rationale** The molecular basis for selective liver X receptor beta (LXRβ/NR1H2) agonism in A
Score: 0.724 · neuroscience · 2026-04-26
FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytopla
Score: 0.718 · neurodegeneration · 2026-04-02
## Mechanistic Overview Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides starts from the claim that modulating
Score: 0.713 · neurodegeneration · 2026-04-02
## Mechanistic Overview Purinergic Signaling Polarization Control starts from the claim that modulating P2RY1 and P2RX7
Score: 0.710 · neurodegeneration · 2026-05-01
LRRK2 G2019S mutations cause autosomal dominant PD through hyperactivation that impairs vesicular trafficking via Rab GT
Score: 0.709 · neurodegeneration · 2026-04-02
## **Molecular Mechanism and Rationale** The lysyl oxidase (LOX) family comprises six enzymes—LOX, LOXL1, LOXL2, LOXL3,
Score: 0.685 · unknown disease · 2026-04-26
Aquaporin-4 (AQP4) is normally highly polarized to astrocyte end-feet surrounding blood vessels, critical for glymphatic
Score: 0.680 · neurodegeneration · 2026-04-28
Impaired mitochondrial dynamics and reduced mitophagy represent a shared energy crisis converging on synaptic vulnerabil
Score: 0.678 · alzheimers · 2026-04-28
40 Hz neural activity induces Ca2+ oscillations in microglia through P2X7 receptor activation, promoting TREM2 phosphory